ELUTE
Elute, Inc. is a clinical-stage company and an emerging leader in the development of patented drug-eluting devices with controlled and sustained therapeutic release. They focus on innovative solutions for unmet clinical needs, particularly in orthopedic infections, with products like EP Granules with Tobramycin designed for local antibiotic delivery to treat bone infections. The company is committed to translating science into novel products that enable patients to lead active, fulfilling lives, and is actively involved in clinical trials and patent development to advance their medical solutions.
Industries
Nr. of Employees
small (1-50)
ELUTE
Products
Antibiotic-loaded resorbable bone void filler (investigational)
A synthetic, resorbable bone void filler engineered to deliver a broad‑spectrum antibiotic locally for approximately eight weeks, minimize systemic exposure, resorb over time, and allow new bone growth; intended for surgical treatment of periprosthetic joint infections.
Antibiotic-loaded resorbable bone void filler (investigational)
A synthetic, resorbable bone void filler engineered to deliver a broad‑spectrum antibiotic locally for approximately eight weeks, minimize systemic exposure, resorb over time, and allow new bone growth; intended for surgical treatment of periprosthetic joint infections.
Services
Clinical trial sponsorship and coordination for investigational implantable devices
Sponsorship and operational coordination of prospective, multicenter, randomized, blinded pivotal clinical trials for investigational implantable bone graft devices, including site partnerships and participant protections.
Preclinical testing and analytical assay development
Design and execution of preclinical infection prevention/treatment studies in animal models and development of analytical assays to quantify polymer-controlled antibiotic release.
Clinical trial sponsorship and coordination for investigational implantable devices
Sponsorship and operational coordination of prospective, multicenter, randomized, blinded pivotal clinical trials for investigational implantable bone graft devices, including site partnerships and participant protections.
Preclinical testing and analytical assay development
Design and execution of preclinical infection prevention/treatment studies in animal models and development of analytical assays to quantify polymer-controlled antibiotic release.
Expertise Areas
- Clinical trial management for investigational implantable devices
- Drug-eluting implant development
- Orthopedic infection therapeutics
- Polymer and biomaterials engineering
Key Technologies
- Polymer-controlled drug delivery
- Polymer-ceramic composite biomaterials
- Resorbable calcium-salt (carbonate/apatite) materials
- Antibiotic-eluting bone void fillers